Phase 1, IND and toxicity management @myESMO #ESMOTAT26 with YOC: our first mission to better define dose and toxicites with new design and new tools with #Dr Kaissa Ouali @GustaveRoussy @GRAlumni and #Madeline Pe @EortcT
Christophe Massard
@drcmassard
MD PhD, Medical Oncologist, Head of the DITEP @gustaveroussy
1.1K Following 2.1K Followers 11K Posts
Latest posts 5
SCOPP2025 #essaisprecoces We need new drugs for patients and RadioLigant therapies will be part of our future
SCOPP2025 #essaisprecoces: happy birthday! 15 years ago, our national cancer institute created the phase 1 trials network with a vision and a strong support for early clinical trials and molecular screening
SCOP2025 early clinical trials in France: FAST TRACK is back for phase 1 trials and kudos to all: ANSM, AIS, CLIPP, CPP and Pharma
#MCCRWorhshop Common errors in statistics with Murielle Mauer: the demon in détails @eortc @myESMO